日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study

RILA血液生物标志物作为匹配队列研究中放射诱发肉瘤的预测因子

Mirjolet, C; Merlin, J L; Truc, G; Noël, G; Thariat, J; Domont, J; Sargos, P; Renard-Oldrini, S; Ray-Coquard, I; Liem, X; Chevreau, C; Lagrange, J L; Mahé, M A; Collin, F; Bonnetain, F; Bertaut, A; Maingon, P

Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)

非转移性前列腺癌患者管理标准、方案和建议摘要(2001 年)

Villers, A; Pommier, P; Bataillard, A; Fervers, B; Bachaud, J M; Berger, N; Bertrand, A F; Bouvier, R; Brune, D; Daver, A; Fontaine, E; Haillot, O; Lagrange, J L; Molinie, V; Muratet, J P; Pabot du Chatelard, P; Peneau, M; Prapotnich, D; Ravery, V; Richaud, P; Rossi, D; Soulie, M

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)

非小细胞肺癌患者管理标准、方案和建议总结报告(2000 年)

Depierre, A; Lagrange, J L; Theobald, S; Astoul, P; Baldeyrou, P; Bardet, E; Bazelly, B; Bréchot, J M; Breton, J L; Douillard, J Y; Grivaux, M; Jacoulet, P; Khalil, A; Lemarié, E; Martinet, Y; Massard, G; Milleron, B; Molina, T; Moro-Sibilot, D; Paesmans, M; Pujol, J L; Quoix, E; Ranfaing, E; Rivière, A; Sancho-Garnier, H; Souquet, P J; Spaeth, D; Stoebner-Delbarre, A; Thiberville, L; Touboul, E; Vaylet, F; Vergnon, J M; Westeel, V

Establishment of two new human bladder carcinoma cell lines, CAL 29 and CAL 185. Comparative study of cell scattering and epithelial to mesenchyme transition induced by growth factors.

建立了两种新的人类膀胱癌细胞系,CAL 29 和 CAL 185比较研究了生长因子诱导的细胞扩散和上皮间质转化

Cattan N, Rochet N, Mazeau C, Zanghellini E, Mari B, Chauzy C, Stora de Novion H, Amiel J, Lagrange J L, Rossi B, Gioanni J